The ethics of testing a test: randomized trials of the health impact of diagnostic tests for infectious diseases.


Dowdy, DW; Gounder, CR; Corbett, EL; Ngwira, LG; Chaisson, RE; Merritt, MW; (2012) The ethics of testing a test: randomized trials of the health impact of diagnostic tests for infectious diseases. Clinical infectious diseases, 55 (11). pp. 1522-6. ISSN 1058-4838 DOI: https://doi.org/10.1093/cid/cis736

Full text not available from this repository.

Abstract

: In the last decade, many new rapid diagnostic tests for infectious diseases have been developed. In general, these new tests are developed with the intent to optimize feasibility and population health, not accuracy alone. However, unlike drugs or vaccines, diagnostic tests are evaluated and licensed on the basis of accuracy, not health impact (eg, reduced morbidity or mortality). Thus, these tests are sometimes recommended or scaled up for purposes of improving population health without randomized evidence that they do so. We highlight the importance of randomized trials to evaluate the health impact of novel diagnostics and note that such trials raise distinctive ethical challenges of equipoise, equity, and informed consent. We discuss the distinction between equipoise for patient-important outcomes versus diagnostic accuracy, the equity implications of evaluating health impact of diagnostics under routine conditions, and the importance of offering reasonable choices for informed consent in diagnostic trials.

Item Type: Article
Faculty and Department: Faculty of Infectious and Tropical Diseases > Dept of Clinical Research
PubMed ID: 22918990
Web of Science ID: 310966200019
URI: http://researchonline.lshtm.ac.uk/id/eprint/504809

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
278Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Impact and interest
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item